What does Plus Therapeutics, Inc. do?

Jun 22 2025 06:32 PM IST
share
Share Via
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing cancer treatments, with a market cap of $10.18 million and recent quarterly net sales of $1 million and a net loss of $17 million.
Overview:
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing treatments for cancer patients, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company. Financial Snapshot: Most recent Net Sales: 1 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -17 Million (Quarterly Results - Mar 2025) Market cap: USD 10.18 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: 0.42 Return on Equity: 99.95% Price to Book: -0.43 Contact Details: Address: 4200 Marathon Blvd Ste 200, AUSTIN TX: 78756-3433 Tel: 1 858 4580900 Website: http://www.plustherapeutics.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Plus Therapeutics, Inc. technically bullish or bearish?
Sep 20 2025 07:37 PM IST
share
Share Via
Is Plus Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:12 PM IST
share
Share Via
Is Plus Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 08:46 AM IST
share
Share Via
Is Plus Therapeutics, Inc. technically bullish or bearish?
Jun 25 2025 08:39 AM IST
share
Share Via
Who are in the management team of Plus Therapeutics, Inc.?
Jun 22 2025 10:25 PM IST
share
Share Via
How big is Plus Therapeutics, Inc.?
Jun 22 2025 05:53 PM IST
share
Share Via